Emovi

Emovi is a healthcare innovation company based in Laval, Quebec, Canada, founded in 2007. The company specializes in advanced medical devices aimed at enhancing the assessment and treatment of knee joint function, helping patients regain active lifestyles. The flagship product, the KneeKG System, is an AI-powered medical device that accurately measures the 3D dynamic alignment of the knee. This FDA-cleared, Health Canada approved, and CE marked technology provides real-time data through a process called Knee Kinesiography. It assists orthopedic surgeons and healthcare professionals in making informed decisions for patients with various knee conditions, including osteoarthritis and ligament injuries. Emovi's technology enhances traditional imaging methods by delivering immediate, actionable insights that improve patient outcomes and streamline healthcare workflows. Emovi collaborates with Quebec’s university research community to refine its technology and holds exclusive rights to commercialize the KneeKG system in Canada, the United States, and Europe. The team is led by CEO Michelle Laflamme, who brings extensive experience in life sciences and business development.

• Employees41
• Founded2007
• Annual Revenue$3500000
• Total Funding$11255084